<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02556177</url>
  </required_header>
  <id_info>
    <org_study_id>114-2015-GES-0017</org_study_id>
    <nct_id>NCT02556177</nct_id>
  </id_info>
  <brief_title>Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2</brief_title>
  <acronym>mTBI-phase2</acronym>
  <official_title>Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ICON plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, non-randomized, prospective, multi-site, parallel group (segment),
      hypothesis-generating study designed to collect data that will aid in future scientific and
      engineering exploration of correlations between clinical neuropsychological assessments and
      GE Research Pack II advanced MR imaging in mTBI patients. The results are primarily intended
      for scientific inquiry and engineering development purposes, and may be used in future
      regulatory submissions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This data-driven study is being conducted for hypothesis generation in population of mild
      traumatic brain injury (mTBI) patients using advanced applications for magnetic resonance
      imaging (MRI) developed by the Sponsor, GE Healthcare (GEHC), and corresponding clinical
      neuropsychological assessments. This data is intended for future use in development of
      specialized MR acquisition, reconstruction, and processing software intended to identify mTBI
      biomarkers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">January 31, 2018</completion_date>
  <primary_completion_date type="Actual">January 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI Image Data Sets</measure>
    <time_frame>Per patient scanning over 3 months</time_frame>
    <description>MRI image data sets collected from subjects who completed the study.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological Assessments</measure>
    <time_frame>Per patient scanning over 3 months</time_frame>
    <description>Neuropsychological assessments collected from subjects who completed the study.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">477</enrollment>
  <condition>Concussion</condition>
  <condition>Traumatic Brain Injury</condition>
  <arm_group>
    <arm_group_label>mTBI patient group (Segment 1)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-TBI patients (Segment 2)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI scanning</description>
    <arm_group_label>mTBI patient group (Segment 1)</arm_group_label>
    <arm_group_label>non-TBI patients (Segment 2)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects included as mTBI patients (Segment 1) will:

          1. Be aged ≥15 and ≤50 years old at the time of enrollment;

          2. Be diagnosed with mTBI according to the standard diagnostic procedures at the
             investigational site in a timeframe that meets enrollment criteria for enrollment
             within 72 hours (Visit 1) or 7±2 days (Visit 3) from injury.

          3. Be capable of sufficiently clear communication and language fluency to allow the
             subject to provide written informed consent, or assent with parental or guardian
             consent for minors, and to complete study assessments (as per Section 6.3 - Protection
             of Vulnerable Subjects) for participation in all parts of the study.

        Subjects included as non-mTBI controls (Segment 2) will:

          1. Be aged ≥15 and ≤50 years old at the time of enrollment;

          2. Are of similar characteristics as the mTBI population in terms of gender, age,
             handedness, educational level, and scanner criteria (as per Section 6.1.1 Enrollment
             of non-mTBI controls)

          3. Be capable of sufficiently clear communication and language fluency to allow the
             subject to provide written informed consent, or assent with parental or guardian
             consent for minors, and to complete study assessments (as per Section 6.3 - Protection
             of Vulnerable Subjects), for participation in all parts of the study.

        Exclusion Criteria:

        Subjects will be excluded that have: mTBI

          1. Loss of consciousness (LOC) ≥5 minutes;

          2. Posttraumatic amnesia lasting ≥24 hr following mTBI;

          3. Current or prior (within past 10 years) moderate to severe TBI

          4. Diagnosis of mTBI within the past 6 months;

          5. Epilepsy with recurring seizures in past 10 years;

          6. Drug abuse (except marijuana) in past 10 years based on DAST-10 screening;

          7. Alcohol abuse based on AUDIT-C screening;

          8. Current primary Axis I or II psychiatric disorders, except for disorders classified as
             minor and not expected to impact study conduct or integrity (as detailed in Appendix C
             - Screening Axis I/II Disorders):

          9. History of brain mass, neurosurgery, stroke, white matter disease, and/or dementia;

         10. Known cognitive dysfunction or structural brain disease/malformation;

         11. Structural brain injury on prior neuroimaging findings;

         12. Been prescribed antipsychotic/antiepileptic medications;

         13. Unable (such as due to urgent medical care needs) or unwilling to complete study
             procedures accurately or have any conflict of interest that could affect study
             results, in the opinion of the investigator;

         14. Contraindications to MRI scanning, including:

               -  Current or suspected pregnancy, per site practice;

               -  Other conditions that may constitute a hazard to the subject during study
                  participation, per investigator;

               -  Inability to comply with any part of the site's MR safety policy.

        Subjects will be excluded that have:- non-TBI (controls)

          1. Diagnosis of mTBI within the past 6 months;

          2. Prior (within past 10 years) moderate to severe TBI (GCS &lt;13);

          3. Epilepsy with recurring seizures in past 10 years;

          4. Drug abuse (except marijuana) in past 10 years based on DAST-10 screening;

          5. Alcohol abuse based on AUDIT-C screening;

          6. Current primary Axis I or II psychiatric disorders, except for disorders classified as
             minor and not expected to impact study conduct or integrity (as detailed in Appendix C
             - Screening Axis I/II Disorders):

          7. History of brain mass, neurosurgery, stroke, white matter disease, and/or dementia;

          8. Known cognitive dysfunction or structural brain disease/malformation;

          9. Structural brain injury on prior neuroimaging findings;

         10. Been prescribed antipsychotic/antiepileptic medications;

         11. Unable (such as due to urgent medical care needs) or unwilling to complete study
             procedures accurately or have any conflict of interest that could affect study
             results, in the opinion of the investigator;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Miranda, MD</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California-San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92161</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universtiy of Miami Health System</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical College</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Neurological Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 7, 2015</study_first_submitted>
  <study_first_submitted_qc>September 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2015</study_first_posted>
  <results_first_submitted>September 4, 2018</results_first_submitted>
  <results_first_submitted_qc>September 9, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 10, 2019</results_first_posted>
  <last_update_submitted>September 9, 2019</last_update_submitted>
  <last_update_submitted_qc>September 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TBI</keyword>
  <keyword>MR</keyword>
  <keyword>mTBI</keyword>
  <keyword>NFL</keyword>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 14, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT02556177/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>mTBI Patient Group (Segment 1)</title>
          <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)
MRI: MRI scanning</description>
        </group>
        <group group_id="P2">
          <title>Non-TBI Patients (Segment 2)</title>
          <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
MRI: MRI scanning</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="325"/>
                <participants group_id="P2" count="152"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="283"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Subjects did not complete all 4 visits</title>
              <participants_list>
                <participants group_id="P1" count="283"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Segment 1 consisted of adolescent and adult mTBI patients who recently sustained head injury. Segment 2 consisted of subjects who were enrolled as a control population.</population>
      <group_list>
        <group group_id="B1">
          <title>mTBI Patient Group (Segment 1)</title>
          <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)
MRI: MRI scanning</description>
        </group>
        <group group_id="B2">
          <title>Non-TBI Patients (Segment 2)</title>
          <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
MRI: MRI scanning</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="325"/>
            <count group_id="B2" value="152"/>
            <count group_id="B3" value="477"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>8 subjects in Segment 1 did not collect age, as a result the overall subjects to be counted for age is 317.
13 subjects in Segment 2 did not collect age, as a result the overall subjects to be counted for age is 139.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="317"/>
                    <count group_id="B2" value="139"/>
                    <count group_id="B3" value="456"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="168"/>
                    <measurement group_id="B2" value="76"/>
                    <measurement group_id="B3" value="244"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="212"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>8 subjects in Segment 1 did not collect gender, as a result the overall subjects to be counted for gender is 317.
13 subjects in Segment 2 did not collect gender, as a result the overall subjects to be counted for gender is 139.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="317"/>
                    <count group_id="B2" value="139"/>
                    <count group_id="B3" value="456"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="76"/>
                    <measurement group_id="B3" value="217"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="176"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="325"/>
                    <count group_id="B2" value="152"/>
                    <count group_id="B3" value="477"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="325"/>
                    <measurement group_id="B2" value="152"/>
                    <measurement group_id="B3" value="477"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>MRI Image Data Sets</title>
        <description>MRI image data sets collected from subjects who completed the study.</description>
        <time_frame>Per patient scanning over 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>mTBI Patient Group (Segment 1)</title>
            <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)
MRI: MRI scanning</description>
          </group>
          <group group_id="O2">
            <title>Non-TBI Patients (Segment 2)</title>
            <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
MRI: MRI scanning</description>
          </group>
        </group_list>
        <measure>
          <title>MRI Image Data Sets</title>
          <description>MRI image data sets collected from subjects who completed the study.</description>
          <units>Images collected</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="152"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Study Visit 1 images collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study Visit 2 images collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="290"/>
                    <measurement group_id="O2" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study Visit 3 images collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="240"/>
                    <measurement group_id="O2" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Study Visit 4 images collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="218"/>
                    <measurement group_id="O2" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total number of images collected</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="827"/>
                    <measurement group_id="O2" value="484"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Neuropsychological Assessments</title>
        <description>Neuropsychological assessments collected from subjects who completed the study.</description>
        <time_frame>Per patient scanning over 3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>mTBI Patient Group (Segment 1)</title>
            <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)
MRI: MRI scanning</description>
          </group>
          <group group_id="O2">
            <title>Non-TBI Patients (Segment 2)</title>
            <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
MRI: MRI scanning</description>
          </group>
        </group_list>
        <measure>
          <title>Neuropsychological Assessments</title>
          <description>Neuropsychological assessments collected from subjects who completed the study.</description>
          <units>Neuropsychological assessments</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="152"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Visit 1 Neuropsychological assessments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 2 Neuropsychological assessments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="303"/>
                    <measurement group_id="O2" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 3 Neuropsychological assessments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244"/>
                    <measurement group_id="O2" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Visit 4Neuropsychological assessments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="222"/>
                    <measurement group_id="O2" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total number of Neuropsychological assessments</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="853"/>
                    <measurement group_id="O2" value="492"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Each visit lasted approximately 90 minutes.</time_frame>
      <desc>Subjects were followed for adverse events and device effects from the time they arrived for each study visit (immediately after providing informed consent for the first visit, and upon arriving to the study area for each subsequent visit,) until the subject left the study area after each visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>mTBI Patient Group (Segment 1)</title>
          <description>1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
Patients in the acute period following recent diagnosis of mild traumatic brain injury (mTBI)
MRI: MRI scanning</description>
        </group>
        <group group_id="E2">
          <title>Non-TBI Patients (Segment 2)</title>
          <description>Control subjects with no recent mild traumatic brain injury. 1.5T or 3.0T MRI brain scanning with research sequences at 3 to 4 intervals in the acute period, with psychological cognitive evaluations at each MR visit
MRI: MRI scanning</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="325"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="325"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="325"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <description>Pain and discomfort</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>ACL tear</sub_title>
                <description>Participant tore her ACL playing football between visits 3 and 4. Had surgery to repair.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Peripheral Nerve Stimulation</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Claustrophobia</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="325"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="152"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="325"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="152"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Strohmeyer</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>609-865-7423</phone>
      <email>john.strohmeyer@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

